Please login to the form below

Not currently logged in
Email:
Password:

IPO

This page shows the latest IPO news and features for those working in and with pharma, biotech and healthcare.

Mega-mergers dominate as buoyant markets lift biopharma

Mega-mergers dominate as buoyant markets lift biopharma

The biggest biotech flotation in the first six months was the $348.5 IPO in June by BridgeBio, the San Francisco biotech focused on genetic diseases.

Latest news

More from news
Approximately 3 fully matching, plus 93 partially matching documents found.

Latest Intelligence

  • Is China ready for a pharmaceutical gold rush?

    The first company to list, Ascletis Pharma Inc, was valued at $2bn when its IPO closed on 1 August.

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    It launched an IPO in the US two years ago, but now its public offering in China has helped swell its coffers enormously – which will help fuel its big ambitions.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    scale.”. Having just raised a gargantuan $903m via an IPO on the newly deregulated Hong Kong exchange, the company is bullish about becoming one of those Chinese-headquartered global pharma companies, ... Tencent’s WeDoctor, which produces diagnosis

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    The company launched its IPO on the Nasdaq in 2013, and those years of ups and downs mean it is well known to investors – if not yet a household name.

  • Deal Watch January 2018

    Denali had also been busy having completed a $250m IPO in early December.  The company has a focus in neurodegenerative diseases and a technology, Antibody Transport Vehicle (ATV) technology, which can

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Novimmune appoints Guillaume de Sampaïo Novimmune appoints Guillaume de Sampaïo

    During that time he contributed to the development of the company's clinical trial portfolio and the facilitation of its successful US IPO during 2014. .

  • Kite Pharma names Cynthia Butitta as CFO Kite Pharma names Cynthia Butitta as CFO

    Her other previous roles include chief financial officer and chief operating officer of Telik where she was responsible for securing over $450m through an initial public offering (IPO).

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics